Related Experiment Video

Updated: May 10, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1

Yiwei Lin1, Hong Chen, Zhenghui Hu

  • 1Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.

FEBS Letters
|June 26, 2013
PubMed

Insights

MicroRNAs are vital in cancer development. Our study shows miR-26a down-regulation in bladder cancer, inhibiting tumor cell growth and motility by targeting HMGA1, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are critical regulators of gene expression implicated in tumorigenesis.
  • Aberrant miRNA expression is frequently observed in various cancers, including bladder cancer.
  • Specific miRNAs, like miR-26a, are emerging as key players in cancer development.

Purpose of the Study:

  • To investigate the role of miR-26a in human bladder cancer.
  • To identify potential targets of miR-26a in bladder cancer cells.
  • To explore the therapeutic implications of miR-26a in bladder cancer.

Main Methods:

  • Analysis of miR-26a expression levels in human bladder cancer tissues.
  • Functional studies involving forced expression of miR-26a in the T24 bladder cancer cell line.
  • Validation of High-mobility group AT-hook 1 (HMGA1) as a direct target of miR-26a.

Main Results:

  • Frequent down-regulation of miR-26a was observed in human bladder cancer tissues.
  • Forced expression of miR-26a significantly inhibited proliferation and motility of T24 bladder cancer cells.
  • HMGA1 was confirmed as a novel, direct target of miR-26a in the context of bladder cancer.

Conclusions:

  • miR-26a plays a significant role in the molecular etiology of bladder cancer.
  • The miR-26a/HMGA1 axis is a critical pathway in bladder cancer progression.
  • miR-26a represents a potential biomarker and therapeutic target for bladder cancer treatment.
Keywords:
Bladder cancerCell cycleHMGA1High mobility group AT-hook 1InvasionMicroRNAMigrationhigh mobility group AT-hook 1miR-26amiRNAmicroRNA

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Mouse Bladder Wall Injection03:48

Mouse Bladder Wall Injection

Published on: July 12, 2011

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...